Snapshot
DuPont de Nemours, Inc. reported $1.68B of revenue in Q1 2026, up 4.3% year over year, with diluted EPS of $0.39 and an operating margin of 11.1%.
- Revenue
- $1.68B
- YoY growth
- +4.3%
- Diluted EPS
- $0.39
- Operating margin
- 11.1%
$1.68B
Revenue
+4.3%
YoY growth
$0.39
Diluted EPS
11.1%
Operating margin
01 Key takeaways
What management said
- •Earlier today, we reported our first quarter financial results, which exceeded our previously communicated guidance.
- •Through disciplined commercial and operational execution, we delivered organic sales growth of 2%, 130 basis points of pro forma margin expansion, and double-digit adjusted EPS growth.
- •As a result of our first quarter performance, along with price increases due to the Middle East conflict, we are raising our full year 2026 financial guidance.
- •On the next slide, I will cover the progress we are making on driving growth and continuous improvement.
- •We are confident in Arclin's ability to continue to drive growth and opportunity for the employees and customers of the combined businesses.
- •We continue to reduce our environmental footprint and increase the use of renewable energy sources across our operations while maintaining a strong focus on execution and discipline.
- •Safety and culture continue to differentiate DuPont with record safety performance and high employee engagement, reinforcing the connection between what we do every day and the value we create for our customers.
- •They are designed to drive growth through innovation, operational excellence, and accountability across our value chain, while also advancing progress in areas such as climate action, circularity, safety, and responsible sourcing.
- •We've strengthened our performance-based culture with a clear emphasis on growth and continuous improvement, reinforced by the launch of our refreshed core values.
- •From a commercial standpoint, we are making steady progress in demand generation and pipeline discipline.
- •Across the businesses, we are advancing targeted sales plays that bring together our technologies and application expertise to address specific end markets where we see attractive growth and differentiated value.
- •These efforts are driving better visibility, improved conversion, and stronger alignment between our commercial team and customers' highest value needs, improving the quality and durability of our pipeline.
What went well
- •Net sales of $1.7 billion were up 4% versus the year-ago period on 2% organic sales growth and a 2% benefit from currency.
- •Operating EBITDA of $414 million increased 15% year-over-year, resulting in operating EBITDA margin of 24.6%, an increase of 230 basis points; on a pro forma basis EBITDA rose 10% with 130 basis points of margin expansion.
- •Adjusted EPS of $0.55 increased 53% year-over-year on a reported basis and 20% on a pro forma basis.
- •Healthcare sales were up high single digits organically, led by continued strength in medical packaging and biopharma, with the Liveo biopharma business showing a nice recovery in demand.
- •Transaction adjusted free cash flow was $147 million with related conversion of 65%, described as a solid start to the year.
- •Completed the Aramids divestiture on April 1st for about $1.2 billion gross proceeds (about $1.1 billion net) and announced a $275 million ASR.
What went wrong
- •Water sales were down low to mid-single digits organically as logistics disruptions in the Middle East prevented about $10 million of sales from shipping; excluding that impact water would have been about flat to slightly down.
- •Construction markets remained weak, with building technologies organic sales down low single digits on continued North America residential weakness.
- •Diversified Industrials organic sales were about flat in the quarter.
- •Printing and packaging businesses declined, driven by the inks business in home and office printing against a tough comp from a strong prior-year first quarter.
- •A stronger U.S. dollar reduced the expected full year currency benefit to less than 1%.
Guidance changes
| Metric | Period | Previous | Current | Change |
|---|---|---|---|---|
Performance breakdown
| Metric | YoY change | Reason |
|---|---|---|
Earnings call themes & trends
| Topic | Previous mention | Current period | Trend |
|---|---|---|---|